Fermion
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
Personally, I am thinking of waiting to a price under $79
Yes, I think we should.
Personally, I am thinking of waiting to a price under $79
good for you Fermion
I know nothing of EXAS except it is down 6% today. Probably a little risky for me, even though I do trade in ECYT which is even further from a phase 3 drug or a release. The advantage in ECYT is they have more cash per share than the current share price which gives you sort of a bottom. EXAS seems to have only a couple bucks in cash and a $18 share price.
I have not yet rebought Gilead even though it is 78.50 today. I have a buy order in for 500 $78.30 and could nudge it up but really in no hurry. The way it has been trading it might dip to $78.30 any time now.
EXAS bottomed out 9/29 at approx $17.60 and climb to $19.50 earlier today. Just for grins, had you invested that 500 x $78.30 and were lucky enough to buy EXAS at the low you would be up $4226.
Reason for the pop is that doctors who were the most frequent prescribers abruptly stopped ordering the test. After EXAS investigated the reason was that pressure was put on them (financial/insurance etc.) because it was not included in HEDIS. As of today it is confirmed that EXAS is included in HEDIS. The shorts were using this misinformation to drop the stock.
The Healthcare Effectiveness Data and Information Set (HEDIS) is a tool used by more than 90 percent of America's health plans to measure performance on important dimensions of care and service.
"Should" be clear sailing from here. Fingers crossed.